CN101849967B - Medicament for curing apoplexy hemiplegy sequela and preparation method thereof - Google Patents
Medicament for curing apoplexy hemiplegy sequela and preparation method thereof Download PDFInfo
- Publication number
- CN101849967B CN101849967B CN2010101929750A CN201010192975A CN101849967B CN 101849967 B CN101849967 B CN 101849967B CN 2010101929750 A CN2010101929750 A CN 2010101929750A CN 201010192975 A CN201010192975 A CN 201010192975A CN 101849967 B CN101849967 B CN 101849967B
- Authority
- CN
- China
- Prior art keywords
- medicine
- sequela
- preparation
- treatment
- hemiplegy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to capsules for curing apoplexy hemiplegy sequela, which is prepared form Chinese herbal medicaments as raw materials. The preparation method comprises the following steps of: mixing leech, earthworm and borneol uniformly; pulverizing the mixture into 250 to 300-mesh fine powder; sterilizing; and loading the powder into number 1 capsules to produce the capsule products. The capsules have good recovering and curing effects on symptoms such as akinesia or lallation, stuttering and the like.
Description
Technical field
The present invention relates to a kind of medicine, being specifically related to a kind of is the medicine of the treatment apoplectic hemiplegia sequela of feedstock production with Chinese medicine.The invention still further relates to the preparation method of this medicine.
Background technology
Apoplexy is divided into apoplex involving the channels and collaterals and middle internal organs two big classes, and the apoplex involving the channels and collaterals person does not have generally that mind changes and the state of an illness is lighter, and middle internal organs person often has obnubilation and the state of an illness is heavier.The sickness rate of apoplexy, mortality rate and disability rate are all quite high, it is a kind of disease of serious harm human health, this class disease incidence is hurried, to faint suddenly on ground, syncope, or facial hemiparalysis takes place suddenly, dysphonia, symptoms such as hemiplegia, its serious sequela are exactly the hemiplegia based on dyskinesia, i.e. hemiplegia, also there is not a kind of method that can really cure at present for this class disease, though some treatment apoplectic hemiplegia Chinese medicines are also arranged, and taking effect of having is slow, effect is not too obvious, the price that has is more expensive, especially in outlying mountain area, when paralysis has the disease of apoplectic hemiplegia, because family income is low, living in penury, local medical condition is poor, and wanting to treat needs expensive travelling expenses to go to the flourishing city of medical condition to go to seek medical advice, and adds the medical expense and the expensive medical expenses of hospital, people often select abandoning cure or wait, have therefore incured loss through delay the best opportunity of treatment.Can provide a kind of effect obvious, this class is treated or controlled to low-cost medicine is one of important subject of current medical circle.
Summary of the invention
The objective of the invention is to bring into play traditional Chinese medical science combination drug, provide a kind of effect obvious, the medicine of low-cost treatment apoplectic hemiplegia sequela.
Another goal of the invention of the present invention provides the preparation method of this medicine.
Based on above-mentioned Therapeutic Principle, medicine of the present invention is to be crude drug with following parts of medicines by weight:
The medicine that a kind of apoplectic hemiplegia sequela resumes treatment is characterized in that with following parts of medicines by weight be crude drug:
Hirudo 50～100, Pheretima 30～60, Borneolum Syntheticum 20～40.
Said medicine can be made any dosage form on the pharmaceutics, as decoction, tablet, pill, powder, capsule;
The preferred dosage form of the present invention is a capsule.
The concrete preparation method of the present invention comprises that the following step poly-:
1) with Hirudo, Pheretima, Borneolum Syntheticum according to above-mentioned parts by weight mix homogeneously;
2) crude drug with mix homogeneously is ground into 250～300 purpose fine powders, sterilization, and the capsule of packing into No. 1 is made capsule product.
The present invention is unfavorable to the handicapped or speech that apoplectic hemiplegia causes, symptom such as pronounce indistinctly has the effect that well resumes treatment.
In the prescription of the present invention, Hirudo: removing blood stasis, removing blood stasis stimulates the menstrual flow; Pheretima: imperial salty in the mouth, cold in nature; Return the liver,spleen,kidney warp; The gas raw meat is scurried and is fallen; Has the heat clearing away relieving convulsion, suppressing the hyperactive liver to relieve the wind syndrome, dredge the meridian passage, the diuretic effect of relievining asthma; Borneolum Syntheticum: hot, bitter, be slightly cold GUIXIN, spleen, lung hydrocarbon.The refreshment of having one's ideas straightened out, clearing away heat to alleviate pain.
The present invention is unfavorable to the handicapped or speech that apoplectic hemiplegia causes, symptom such as pronounce indistinctly has the effect that well resumes treatment.
The specific embodiment
Embodiment 1:
Take by weighing raw material by following proportioning:
Hirudo 100g, Pheretima 60g, Borneolum Syntheticum 40g.
Concrete preparation method comprises that the following step poly-:
1) with Hirudo, Pheretima, Borneolum Syntheticum according to above-mentioned parts by weight mix homogeneously;
2) crude drug with mix homogeneously is ground into 250 purpose fine powders, sterilization, and the capsule of packing into No. 1 is made capsule product.
Using method: every day 3 times, each 7.
Embodiment 2:
Take by weighing raw material by following proportioning:
Hirudo 50g, Pheretima 30g, Borneolum Syntheticum 20g.
Concrete preparation method comprises that the following step poly-:
1) with Hirudo, Pheretima, Borneolum Syntheticum according to above-mentioned parts by weight mix homogeneously;
2) crude drug with mix homogeneously is ground into 300 purpose fine powders, sterilization, and the capsule of packing into No. 1 is made capsule product.
Using method: every day 3 times, each 7.
Claims (4)
1. medicine for the treatment of the apoplectic hemiplegia sequela is characterized in that with following parts of medicines by weight be crude drug:
Hirudo 50～100, Pheretima 30～60, Borneolum Syntheticum 20～40.
2. a kind of medicine for the treatment of the apoplectic hemiplegia sequela according to claim 1 is characterized in that: the dosage form of described medicine is a said dosage form on any pharmaceutics.
3. a kind of medicine for the treatment of the apoplectic hemiplegia sequela according to claim 1, it is characterized in that: the dosage form of described medicine is a capsule.
4. a kind of preparation method for the treatment of the medicine of apoplectic hemiplegia sequela according to claim 3 is characterized in that: may further comprise the steps:
1) with Hirudo, Pheretima, Borneolum Syntheticum according to described parts by weight mix homogeneously;
2) crude drug with mix homogeneously is ground into 250～300 purpose fine powders, sterilization, and the capsule of packing into No. 1 is made capsule product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101929750A CN101849967B (en) | 2010-06-02 | 2010-06-02 | Medicament for curing apoplexy hemiplegy sequela and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101929750A CN101849967B (en) | 2010-06-02 | 2010-06-02 | Medicament for curing apoplexy hemiplegy sequela and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101849967A CN101849967A (en) | 2010-10-06 |
| CN101849967B true CN101849967B (en) | 2011-11-09 |
Family
ID=42801755
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101929750A Expired - Fee Related CN101849967B (en) | 2010-06-02 | 2010-06-02 | Medicament for curing apoplexy hemiplegy sequela and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101849967B (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1557467A (en) * | 2004-02-09 | 2004-12-29 | 周宝义 | Extraction and concentration combined pure Chinese medicinal preparation for treating cardiovascular diseases |
| CN101156933A (en) * | 2007-09-28 | 2008-04-09 | 中国人民解放军济南军区青岛第二疗养院 | A medicine for treating cerebrovascular disease |
| CN101411742A (en) * | 2008-11-18 | 2009-04-22 | 山西振东开元制药有限公司 | Capsule for freeing collateral vessels containing astragalus and leech |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100534499C (en) * | 2006-06-05 | 2009-09-02 | 李凤池 | Medicine for treating cerebral thrombus |
| CN101129464A (en) * | 2007-08-21 | 2008-02-27 | 高翔 | Traditional Chinese medicine composition for qi-benefitting blood circulation promoting and eliminating stasis activating meridian and processes for producing same |
| CN101181327B (en) * | 2007-11-30 | 2010-11-24 | 李钦 | Chinese medicine compound preparations for preventing and curing cataptosis and chest bi-syndrome as well as preparation method thereof |
-
2010
- 2010-06-02 CN CN2010101929750A patent/CN101849967B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1557467A (en) * | 2004-02-09 | 2004-12-29 | 周宝义 | Extraction and concentration combined pure Chinese medicinal preparation for treating cardiovascular diseases |
| CN101156933A (en) * | 2007-09-28 | 2008-04-09 | 中国人民解放军济南军区青岛第二疗养院 | A medicine for treating cerebrovascular disease |
| CN101411742A (en) * | 2008-11-18 | 2009-04-22 | 山西振东开元制药有限公司 | Capsule for freeing collateral vessels containing astragalus and leech |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101849967A (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104587050B (en) | A kind of Chinese medicinal body slim patch and preparation method thereof | |
| CN101843811A (en) | Oral preparation special for treating gout | |
| CN101134082A (en) | Traditional Chinese medicine for treating early hemorrhagic stroke | |
| CN104758404A (en) | Three-snake powder composition for treating autoimmune diseases, and preparation method thereof | |
| CN102225153B (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus and preparation method thereof | |
| CN105998245A (en) | Traditional Chinese medicine for improving male sexual functions, and products thereof | |
| CN1985918A (en) | Chinese medicine composition for rheumatic arthritis, rheumatoid arthritis and other diseases | |
| CN102178759B (en) | Traditional Chinese medicine composition for treating rheumatism and preparation method of composition | |
| CN102772611A (en) | Traditional Chinese medicine composition and preparation method and application thereof | |
| CN101849967B (en) | Medicament for curing apoplexy hemiplegy sequela and preparation method thereof | |
| CN101810843B (en) | Medicament for treating nerve system diseases such as cerebrovascular accident, spinal cord injury and senile dementia | |
| CN102988659A (en) | Hyperosteogeny formula and application method thereof | |
| CN101439106A (en) | Medicament for treating apoplexy | |
| CN102670740B (en) | Drug composition for treating soft tissue injuries and preparation process thereof | |
| WO2016127771A1 (en) | Application of 20(r)-ginsenoside rg3 in preparing drug or healthcare product for alleviating or/and treating rheumatoid disease and drug containing 20(r)-ginsenoside rg3 | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN102727632B (en) | Traditional Chinese medicinal capsule for treating cervical spondylosis | |
| CN1166381C (en) | Medicine for treating rheumatoid arthritis, osteoarthritis and ankylosing spondylitis | |
| CN102727773A (en) | Traditional Chinese medicinal capsule for treating blood mucoviscidosis | |
| CN102274428A (en) | Pharmaceutical composition with effect on treating irritable bowel syndrome and preparation method and application thereof | |
| CN105326949A (en) | Traditional Chinese medicine for treating cardiovascular blockage and preparation method thereof | |
| CN113171431A (en) | Capsule for treating rheumatoid and preparation method thereof | |
| CN105327003A (en) | Traditional Chinese medicine for treating cardiovascular diseases and preparation method thereof | |
| CN114601869A (en) | Traditional Chinese medicine capsule for treating chronic lumbocrural pain and preparation method | |
| CN104042703B (en) | A kind of medicated wine being used for the treatment of rheumatic arthritis and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111109 Termination date: 20120602 |